Covid vaccines rolling off the production line

"The world will need as many syringes as doses of vaccine", Unicef said in a statement.

The cities of Yiwu, Ningbo and Shaoxing are targeting key groups with urgent need for vaccinations against COVID-19 following the city of Jiaxing, state-run Global Times quoted another daily, The Paper, as reporting on Saturday.

Officials in Jiaxing city said on Thursday that residents aged between 18 and 59 with "urgent needs" can seek consultations at clinics for a Sinovac Biotech vaccine that the authorities have been giving to groups such as medical workers.

Most of the recipients are set to go overseas or have plans to go overseas in the near future, The Paper reported.

"We are operating at the speed of science", he said.

Throughout the trial, a robust humoral immune response was observed in all vaccine recipients.

The syringes will be used by Covax, the global coronavirus vaccine procurement, production and distribution pool created by the World Health Organization (WHO).

Since Saturday, sources said China has begun inoculating the general public against the coronavirus with an experimental vaccine, which has not yet completed clinical trials.

Bourla stated that in order to seek approval for public use, it must be proved that the COVID-19 vaccine is effective, safe and can be consistently manufactured at the highest quality standards.

BBIBP-CorV is one of at least 10 coronavirus vaccine projects globally to have entered Phase 3 trials, four of which are led by Chinese scientists, according to the World Health Organisation.

This investigational candidate induced antibodies without developing serious side effects in early and mid-stage trials.

Pfizer's vaccine is one of the frontrunners among those being developed around the world.

The WHO said nine candidate vaccines are now being evaluated for inclusion in the COVAX Facility.

"The hope here is that we essentially come up with a medicine that disrupts the virus and ultimately prevents it worsening the condition of a patient", he told the Mail's financial site, This is Money.

The coronavirus has so far claimed 4,634 lives with 85,672 confirmed infections in China.